3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
160
Myelodysplastic Syndromes
44
Leukemia, Myelomonocytic, Chronic
25
Leukemia
16
Myeloproliferative Disorders
11
Recurrence
9
Hematologic Neoplasms
8
Neoplasms
6
Lymphoma, T-Cell, Peripheral
6
Primary Myelofibrosis
5
Leukemia, Biphenotypic, Acute
5
Anemia, Refractory, with Excess of Blasts
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Neoplasm, Residual
4
Multiple Myeloma
4
Lymphoma, Non-Hodgkin
4
Leukemia, Monocytic, Acute
4
Hematologic Diseases
4
GATA2 Deficiency
4
Precursor Cell Lymphoblastic Leukemia-Lymphoma
3
Pathologic Complete Response
3
Pancreatic Neoplasms
3
Neoplasm Metastasis
3
Myelodysplastic-Myeloproliferative Diseases
3
Lymphoma
3
Hodgkin Disease
3
Carcinoma, Non-Small-Cell Lung
3
Breast Neoplasms
3
Polycythemia Vera
2
Lymphoma, T-Cell
2
Interventions
Capecitabine
41
Oxaliplatin
39
Fluorouracil
29
Leucovorin
23
Radiotherapy
21
Cetuximab
14
Bevacizumab
14
Irinotecan
13
Nivolumab
12
Magnetic Resonance Spectroscopy
11
Specimen Handling
9
Surgical Procedures, Operative
8
Folfox protocol
8
Drug Therapy
8
pembrolizumab
7
Radiotherapy, Intensity-Modulated
7
Chemoradiotherapy
7
Biopsy
7
trifluridine tipiracil drug combination
6
Radiation
6
tislelizumab
5
sintilimab
5
regorafenib
5
dehydroftorafur
5
X-Rays
5
Surveys and Questionnaires
5
Sigmoidoscopy
5
Endoscopy
5
Consolidation Chemotherapy
5
spartalizumab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Rectal Neoplasms
×
Azacitidine
×
1 year
×
Clear all
No trials found.